chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Aug2021 12:00 (Batch/Lot number: unknown) at the age of 23 years as dose 2, single and administration date 24Aug2021 12:00 (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation. Relevant medical history included: "Moderate-Egg white" (unspecified if ongoing), notes: Moderate-Egg white, Mild-dairy, gluten, egg yolk, oats. There were no concomitant medications. Past drug history included: Mild-dairy for known allergies Mild-dairy, notes: Moderate-Egg white, Mild-dairy, gluten, egg yolk, oats; Egg yolk for known allergies egg yolk, notes: Moderate-Egg white, Mild-dairy, gluten, egg yolk, oats; Oats for known allergies oats, notes: Moderate-Egg white, Mild-dairy, gluten, egg yolk, oats. The following information was reported: CHILLS (non-serious), FEELING COLD (non-serious) all with onset 25Aug2021 16:00, outcome "recovered" and all described as "Chills/shiver freezing for hours. Fever of 102.3 F.  Fever lasted around 2 days (not at 102 F. the entire time, but above 100 F.)"; PYREXIA (non-serious) with onset 25Aug2021 16:00, outcome "recovered", described as "Fever of 102.3 F. Fever lasted around 2 days (not at 102 F the entire time, but above 100 F.)"; COUGH (non-serious) with onset 25Aug2021 16:00, outcome "recovered", described as "Cough"; HEADACHE (non-serious) with onset 25Aug2021 16:00, outcome "recovered", described as "Headache"; PAIN (non-serious) with onset 25Aug2021 16:00, outcome "recovered", described as "soreness, stiffness/pain"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 25Aug2021 16:00, outcome "recovered", described as "stiffness/pain"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 24Aug2021 12:00, outcome "unknown", described as "patient received first dose and 2 dose on 24-AUG-2021 12:00". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, feeling cold, pyrexia, cough, headache, pain, musculoskeletal stiffness. Additional information: No vaccine in four weeks and no medications in two weeks. Patient did not receive any treatment for the adverse event. No Covid-19 prior vaccination and no Covid-19 tested post vaccination. The lot number for bnt162b2 was not provided and will be requested during follow up. Follow-up (07Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Fever, chills, body aches, very tired, weak, no appetite. Onset happened the following day. I felt better after 24 hours
Daptacel C2129AA Oct 27, 2006 Imm was given in left upper arm, arm became red swollen sore.
Narrative: Person to observe event was marked as physician, although the patient self-report the pain in leg the following day, present was seen 3 days after in ER with leg pain, by ER staff. patient had had 3 doses prior this booster without report complaint, was added to allergy list.
Patient was sitting during the observation period and then lowered himself to the floor stating he felt he was going to 'pass out'. While on the floor patient was observed having jerking movements described as seizure type movements. EMS was called and the team protected patient from injury while allowing for movement and recovery. As the patient was coming out of his episode he was asking for help, and apologizing. He was very pale diaphoretic and had a small 1x1cm abrasion to left elbow and one on left knee approx. 1x1cm. No other injuries, denied any head trauma and none was observed.
myelitis; hearing problems; balance issues; multiple outbreaks of herpes zoster; This spontaneous report has been received from a lawyer, regarding a case in litigation and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiry date were not provided) for routine health maintenance and for the prevention of shingles (herpes zoster). On an unknown date after receiving zoster vaccine live (ZOSTAVAX), the patient suffered multiple outbreaks of herpes zoster, myelitis, hearing problems and balance issues. As a result of these symptoms, the patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms resulted in physical limitations not present prior to using the product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of the patient's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered to be not recovered. The events were determined to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of myelitis was considered to be medically significant. The events of multiple outbreaks of herpes zoster, myelitis, hearing problems and balance issues were determined to be disabling.
Painful left hand/wrist. Injection was in left arm. Very painful hand and thumb continued for approximately 20 days and began to ease.
sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset Mar2021, outcome "not recovered", described as "sore throat".  Additional information: The patient was currently scheduled for the second dose of the Pfizer COVID 19 vaccine on Wednesday (22Mar2021) but still has a sore throat, the patient was asking if he should get the second dose with a sore throat.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling at the site, then swelling progressed from shoulder to elbow, fever and pain.
Hives on stomach, back and legs - about an hour after vaccine given - provider advised to give BENADRYL.
I felt tired, sinus plugged up, headache and sneezing on 07/18/2022. I slept all afternoon and when I woke I still felt bad. I went ahead and took a home test and it was positive. Around day three I did have a sore throat and some coughing, headache lasted about three days, fatigue lasted about a week.  I talked to my doctor on 07/20/2022 and got a prescription of Paxlovid and started on the evening of the 20th.  As of today I still do have fatigue that is lingering.
Felt fine until about two hours later when I was finishing performing a procedure (I am also a physician) and became immediately flush with cold sweat, lightheadedness, and very fatigued. Felt orthostatic really. Had to immediately leave the room and go sit on the bathroom floor. Took 5-10 minutes for me to feel better. After that I felt 100%. Not sure if it's related to vaccine at all though I hadn't probably had enough water that day.
She states she did not eat breakfast but this is normal for her and had coffee this morning, nothing else out of the ordinary. Was very anxious feeling before the vaccine. Pt to ER for dizziness after she received covid vaccine About 5 minutes afterwards she began feeling more anxious, as well as dizzy and lightheaded, vomiting once.  No LOC noted.  At this point feeling a little "foggy" which has persisted.  She has been ambulatory and has no focal weakness or other problems.  No history of reactions to other vaccines in the past. Lightheadedness Vasovagal episode . Nausea,Vomiting. ED visit,Monitoring at vaccine site
Information has been received from a registered nurse, concerning a female patient who was vaccinated with the third dose of Gardasil (yeast) (date unspecified). There was no concomitant medication. The patient developed "little bumps" that developed about 2 days after the vaccination, "mostly near the arm and neck." The nurse reported the bumps did not appear to be hives, but that some of the bumps "appeared to be vesicles." The nurse stated that the vesicles resolved "several days later." The patient sought unspecified medical attention. Additional information has been requested.
Nausea; Joint pain; Itchy Sensation - Near Injection Site; Swelling - Near Injection Site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site), NAUSEA (Nausea) and ARTHRALGIA (Joint pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site). On 23-Jan-2021, the patient experienced NAUSEA (Nausea) and ARTHRALGIA (Joint pain). At the time of the report, VACCINATION SITE PRURITUS (Itchy Sensation - Near Injection Site), VACCINATION SITE SWELLING (Swelling - Near Injection Site), NAUSEA (Nausea) and ARTHRALGIA (Joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient was administered vaccine at 7:40AM. At 7:45 AM patient reported she wasn't feeling well with loss of color, dizziness, syncope episode, nauseous, blurred vision and slow to recover. Patient never passed out, but heart rate dropped to 32. Oxygen remained normal the entire time. 911 was called and arrived around 7:50 and performed a full evaluation on the patient. The patient refused to be transported and was released after recovering, but had someone drive her home.
whooping cough; Initial information was received on 09-Nov-2020 regarding an unsolicited valid serious social media case from a consumer via social media.  This case involves a male patient (unknown age), who experienced whooping cough (pertussis), while the patient was treated with INFLUENZA VACCINE.  Medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient started taking INFLUENZA VACCINE produced by unknown manufacturer, (lot number expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed serious whooping cough (pertussis) (unknown latency) following the INFLUENZA VACCINE. This event was assessed as medically significant.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  Outcome was unknown for the event at the time of reporting.  There will be no information available on the batch number for this case.; Sender's Comments: This poorly document case received from social media concerns a male patient (unknown age) who had pertussis after vaccination with INFLUENZA VACCINE, produced by unknown manufacturer. The time to onset is unknown.  Additional information regarding medical history, condition at the time of vaccination, concomitant medications, laboratory investigation ruling out other etiologies were not reported. Based upon the reported information, the role of vaccine cannot be assessed.
Woke up with sore arm,3 inch circular rash around site of vaccine day 1. Developed into tiredness, weakness, chills, rash (not itchy) extended to both arms and both legs and feet. No appetite. General feeling unwell for about 10 days. Took tylenol (normally takes).
The pt experienced a seizure on 2/22/01 at 4:00 PM.
Approximately 12 days after the shot, May 12, 2021, I began feeling numbness(pins and needles) in my feet. My feet felt swollen and it was hard to stand or walk. I dismissed it and went on with my day. For the next 11 days my symptoms progressively got worse. On May 16, 2021 my friends and I traveled. By the end of the trip my legs became very weak, hard to walk and trying to stand up was becoming almost impossible. Returning from travel, May 23, 2021, I had a constant numbness in my legs and hands. I decided to go to my parents, because I live alone, just incase I didn't get better. On May 29, had 2 falls. Admitted to hospital on June 2, diagnosed with GBS and treated with 5 rounds of Plasmaqherisos. discharged June 14 to outpatient physical therapy
Fatigued, headache, dizziness on 9/21/18 - 9/24/18. Altered mental status, incoherent, syncope, slurred speech - 9/24/18. Then admitted to medical center.
Information has been received from a physician for GARDASIL, a Pregnancy Registry product, concerning an actually 16 year old female patient with no pertinent medical history and no drug reactions or allergies, who on 16-AUG-2012 was vaccinated with the first dose of GARDASIL (lot number not reported), on 23-FEB-2011, the patient received the second does of GARDASIL (Lot number 668261/1397AA) and on 28-OCT-2011, the patient received the third dose of GARDASIL (Lot number 668261/1397AA). Doses and routes were not reported for any of the vaccine administered. There was no concomitant medications. The physician reproted that the patient completed the "3 shots" of the GARDASIL and later found out that she was pregnant. On an unspecified date serum thyroid-stimulating hormone (TSH) (blood work) was performed, results not provided. It was reported that the patient did not remember her last menstrual period but she thought it was in September. Additional information is not expected.
Breast cancer surgery; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Breast surgery) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21B, 031L20A and 029L20A) for COVID-19 vaccination.     It was reported that Patient was not allergic, never tested positive for Covid-19.  Concomitant products included THYROID (ARMOUR THYROID) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2022, the patient experienced VACCINATION COMPLICATION (Breast surgery). At the time of the report, VACCINATION COMPLICATION (Breast surgery) outcome was unknown.            Reportedly, patient was not an Anti-Vaccine. Patient did not have any reaction on previous doses of the Moderna COVID-19 Vaccine and didn't have any vaccine in between 1 month near booster.  Patient took 1st Booster on 23Aug2021 and had breast cancer surgery.  No treatment information was reported.   This case was linked to MOD-2022-538004 (Patient Link).
SLEPT ALOT; CHILLS; SLIGHT HEADACHE; INJECTION SITE PAIN ON HER RIGHT ARM; FATIGUE; NAUSEA; This spontaneous report received from a patient concerned a 69 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included multiple chemical syndrome, and many allergies to many different drugs. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808390 expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 to right arm for prophylactic vaccination.  No concomitant medications were reported.  On 26-MAR-2021, the subject experienced slept a lot. On 26-MAR-2021, the subject experienced chills. On 26-MAR-2021, the subject experienced slight headache. On 26-MAR-2021, the subject experienced injection site pain on her right arm. On 26-MAR-2021, the subject experienced fatigue. On 26-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slept a lot, and chills, slight headache, injection site pain on her right arm, and fatigue on 29-MAR-2021, and was recovering from nausea. This report was non-serious.
Worse headache of her life. No history of headaches. Started on 4/21/21
RIGHT THIGH SWOLLEN NO TENDERNESS OR WARMTH . PT DESCRIBED AS ITCHY. WALKING WELL. PLAYFUL
Patient has a lot of soreness, some redness with warmth on or around injection site. Arm has been sore since vaccination. Suggested patient take benadryl for a few days to help symptoms resolve.
Large red area noticed 13 days after injection administered. Arm was very tender, sore after initial injection with large slightly swollen area present for approximately 10 days after injection. Photos available if needed.
Pain, redness in site of immunization. On exam, local cellulitis. Started on Bactrim, 20 ml twice a day x 10 days.
right arm felt achy and tingly; two previous anthrax injection site began to weep a watery discharge, stopped by next moring, leaving two scabs
Woke up at 5:30 am the morning after with sore left arm and very limited range of motion. The following day the pain went down to my knee joint and both areas have remained painful to this day?.almost 3 weeks later. Today I can hardly walk the pain is so intense in the bursa area of my knee. The pain remains in the elbow joint of my left arm, but is not as intense.
Pain in rt. shoulder, deltoid and bicep. Treating with heat, cream. Little relief.
Sore arm 2 days/3rd day started with pain right side lymph nodes, next day pain on both sides of lymph nodes and then couldn't swallow having a hard time eating and the pain was really hard the swelling got real large underneath my chin and bottom part about my neck, had to go-to my doctor today for swelling in pain and both sides of the throat look like white pus on inside of my mouth and also just wanted to note my wife after the first day she felt like she had the a fever for two days chills and everything and eventually that went away for her. My doctor put me on amoxicillin today or no it was a penicillin and it's $875 milligrams twice a day. She thinks it was just tonsillitis but still having problems doing a lot of salt water ibuprofen aspirin drinking lots of chicken noodle soup so I hope that helps you out
Moderna COVID-19 Vaccine  Mild case of side effects (fatigue, headache, muscle aches, and fever). Took 2 Ibuprofen tablets and lots of fluids and bed rest.  Effects lasted about 36 hours.
Pain to right arm, not able to left more than five pounds, and not able to move right arm with full range of motion.
for 2 days patient experienced fever, chills, joint aches, and was hot/cold patient took Aleve for muscle pain
Breakthrough case admission after three vaccines Pfizer 4/8/21 Lot# ER8733;  Pfizer 4/29/21 Lot# EW0150; Pfizer 1/5/22 Lot# FL3198
A lot of it leaked out over the daughter's leg and her hand; Case reference number US-BN-2022-001528 is a spontaneous case report initially received on 05-Jul-2022 from consumer (reference number: USBAV22-0473) and concerns a female patient of unknown age.  The patient's medical history and concomitant medication details were not provided.  On 05-Jul-2022, while her 19-months-old daughter was receiving first dose of Rabavert (Rabies Virus (Inactivated, Strain Flury LEP); batch number unknown) (see case US-BN-2022-001474) a lot of it leaked out over the daughter's leg and her hand (explicitly coded as 'accidental exposure to product').  At the time of this report, it was unknown if the patient experienced any adverse event due to Rabavert.  This case is linked with to the case US-BN-2022-001474, daughter case.  Additional information received on 12-Jul-2022 from Bavarian Nordic included local case ID.; Reporter's Comments: A female patient of unknown age was exposed to product while her 19-months-old daughter was receiving first dose of Rabavert and a lot of it leaked out over the daughter's leg and her hand, which is considered as accidental exposure to product. No associated adverse events were reported. Accidental exposure to product is listed per company convention. The patient's medical history and concomitant medication details were not provided. Accidental exposure to product is assessed as not related to Rabavart, but to a human factor. The case is non-serious.; Sender's Comments: A female patient of unknown age was exposed to product while her 19-months-old daughter was receiving first dose of Rabavert and a lot of it leaked out over the daughter's leg and her hand, which is considered as accidental exposure to product. No associated adverse events were reported. Accidental exposure to product is listed per company convention. The patient's medical history and concomitant medication details were not provided. Accidental exposure to product is assessed as not related to Rabavart, but to a human factor. The case is non-serious.
Recurring vertigo and dizziness.  Vertigo started 3 days after vaccine, returned 4 days after first spell, and have been feeling slighly dizzy for the next few days.  Had another vertigo spell today, which was brief.  I feel a bit dizzy with pressure on left ear and head. I suffer from seasonal allergies.
Headache; cough; tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid), HEADACHE (Headache) and COUGH (cough) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced COVID-19 (tested positive for Covid). On an unknown date, the patient experienced HEADACHE (Headache) and COUGH (cough). At the time of the report, COVID-19 (tested positive for Covid) was resolving and HEADACHE (Headache) and COUGH (cough) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Alopecia areata. Random bald spot on back side of head. Slightly larger than a quarter. Never had alopecia in the past. Did not seek medical attention. Hair is growing back after approximately 2 months.